Z-0675-2019 Class II Terminated

Recalled by Tosoh Bioscience Inc — Grove City, OH

FDA device recall Z-0675-2019 was initiated by Tosoh Bioscience Inc on Nov 30, 2018 and is designated Class II. The recall status is terminated (terminated Jan 14, 2021). Affected quantity: 992 units.

Recall details

Product Type
Devices
Report Date
Jan 2, 2019
Initiation Date
Nov 30, 2018
Termination Date
Jan 14, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
992 units

Product description

ST AIA-PACK Homocysteine (HCY) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of homocysteine in human serum, heparinized plasma or EDT A plasma on TOSOH AIA System Analyzers. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia or homocysteinuria.

Distribution pattern

US Nationwide

Code information

all lots

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0675-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Tosoh Bioscience Inc? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-0675-2019. Report a data issue: hello@regdatalab.com.